Pennystock
Universal Ibogaine’s stock approved by borse Frankfurt
UI's common shares have been listed for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt, under the ticker symbol "JC4". In Canada, UI will continue to trade on the TSX Venture Exchange under the ticker IBO and on the OTCQB under the ticker symbol IBOGF.
$IBO destined to be on top of the TSX-V index
$IBO is one of the handpicked penny stocks in the market today and is racing ahead with full speed, the stock’s financial figures are pretty neat and is expected achieve great heights in the days to come, shares are trading yesterday at $0.0500 with a distinctive spike
Nick Karos thrilled by listing of UI on Frankfurt stock exchange
UI CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership."
$HEM announced incorporation of an entirely owned subsidiary
The business is happy to announce that PreCerv Inc. ("PreCerv") has been incorporated as a completely owned subsidiary. A worldwide field of use licence for NCP-01 and its autologous stem cell technology will be acquired by PreCerv from Hemostemix.
Universal Ibogaine Inc. CEO’s ecstatic to work with Blue Digital
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
$HMTXF going up in flash on the OTC
$HMTXF today marked quite an impressive opening in the otc market and is currently trading with a steady pace at $0.1960 with a notable spike
Hemostemix hires new financial advisor to the family
Mr. Rick Groome who has effectively settled 2 securities firm, helping many successful biotechnology companies in providing funds over the last three decades has joined hemostemix as a special financial advisor.
$IBO announced a vital addition of clinical trials directorJulie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$IBO’S CEO comments on the H.C Wainwright
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
SHORT-TERM BULLISH in RENUKA SUGARS !!!#MONDAY>
<#SHORT-TERM>
NSE:RENUKA
{
Why SHREE RENUKA ???
VOLUME during this month is comparatively higher than past 4-5 years volume...(On Monthly candles);
its net profit has been increased drastically from quarters to quarters;
good news is being seen sugar industries;
it's earnings is going to be announced next month (May 28);
Be careful It's a PENNY STOCK;
}
{
BUY: Renuka sugars
Trigger price;-"60-62";
TARGET:-72++;
SL:-55;
The above provided levels are provided based on our RISK-MANAGEMENT !!!
}
} HAPPY TRADING
{
Follow for More exciting trades.. @VK2413
Show your ❤️by 👍to the idea..
Please express your response by comment..
}